CD274 and tuberculosis: A meta-analysis by K. Liu et al. indicates that patients treated with PD-1/PD-L1 blockers had a 35 times higher probability of reactivating TB than the general population, and the mortality was extremely high because 30% of these patients that experienced reactivated TB died [73].